Antitumor activity of an engineered decoy receptor targeting CLCF1–CNTFR signaling in lung adenocarcinoma
出版年份 2019 全文链接
标题
Antitumor activity of an engineered decoy receptor targeting CLCF1–CNTFR signaling in lung adenocarcinoma
作者
关键词
-
出版物
NATURE MEDICINE
Volume 25, Issue 11, Pages 1783-1795
出版商
Springer Science and Business Media LLC
发表日期
2019-11-08
DOI
10.1038/s41591-019-0612-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC
- (2019) D. Ross Camidge et al. Nature Reviews Clinical Oncology
- Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring
- (2019) Yu Shi et al. NATURE
- An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
- (2018) Jianfang Liu et al. CELL
- Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor
- (2018) Matthew R. Janes et al. CELL
- CD10 + GPR77 + Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness
- (2018) Shicheng Su et al. CELL
- Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase
- (2018) Dietrich A. Ruess et al. NATURE MEDICINE
- Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition
- (2018) Gabrielle S. Wong et al. NATURE MEDICINE
- SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo
- (2018) Sara Mainardi et al. NATURE MEDICINE
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
- (2018) Leena Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA-21 in cancer-associated fibroblasts supports lung adenocarcinoma progression
- (2018) Akiko Kunita et al. Scientific Reports
- RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers
- (2018) Robert J. Nichols et al. NATURE CELL BIOLOGY
- Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy
- (2018) Kieren D. Marini et al. Science Translational Medicine
- Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS
- (2017) Zhan Yao et al. NATURE
- A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion
- (2017) Anna Labernadie et al. NATURE CELL BIOLOGY
- Targeting ALK: Precision Medicine Takes on Drug Resistance
- (2017) Jessica J. Lin et al. Cancer Discovery
- IL6 Trans-signaling Promotes KRAS-Driven Lung Carcinogenesis
- (2016) G. D. Brooks et al. CANCER RESEARCH
- Engineering antibody therapeutics
- (2016) Mark L Chiu et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy
- (2016) X. Wu et al. MOLECULAR CANCER THERAPEUTICS
- Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design
- (2016) Jonathan M. L. Ostrem et al. NATURE REVIEWS DRUG DISCOVERY
- Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism
- (2016) P. Lito et al. SCIENCE
- Emerging Strategies for Developing Next-Generation Protein Therapeutics for Cancer Treatment
- (2016) James R. Kintzing et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- BRAF Mutants Evade ERK-Dependent Feedback by Different Mechanisms that Determine Their Sensitivity to Pharmacologic Inhibition
- (2015) Zhan Yao et al. CANCER CELL
- Biochemical and Structural Analysis of Common Cancer-Associated KRAS Mutations
- (2015) J. C. Hunter et al. MOLECULAR CANCER RESEARCH
- The Phyre2 web portal for protein modeling, prediction and analysis
- (2015) Lawrence A Kelley et al. Nature Protocols
- Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts
- (2015) Jean Albrengues et al. Nature Communications
- Acquired resistance to TKIs in solid tumours: learning from lung cancer
- (2014) D. Ross Camidge et al. Nature Reviews Clinical Oncology
- Drugging the undruggable RAS: Mission Possible?
- (2014) Adrienne D. Cox et al. NATURE REVIEWS DRUG DISCOVERY
- Aflibercept—a Decoy VEGF Receptor
- (2014) Kristen K. Ciombor et al. Current Oncology Reports
- Regulation of Hypoxia-inducible Factor 1α (HIF-1α) by Lysophosphatidic Acid Is Dependent on Interplay between p53 and Krüppel-like Factor 5
- (2013) Sei-Jung Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The quest to overcome resistance to EGFR-targeted therapies in cancer
- (2013) Curtis R Chong et al. NATURE MEDICINE
- Neuronal STAT3 activation is essential for CNTF- and inflammatory stimulation-induced CNS axon regeneration
- (2013) M Leibinger et al. Cell Death & Disease
- Cross-Species Functional Analysis of Cancer-Associated Fibroblasts Identifies a Critical Role for CLCF1 and IL-6 in Non-Small Cell Lung Cancer In Vivo
- (2012) S. Vicent et al. CANCER RESEARCH
- CNTF receptor subunit α as a marker for glioma tumor-initiating cells and tumor grade
- (2012) Jie Lu et al. JOURNAL OF NEUROSURGERY
- Methyl-CpG binding column-based identification of nine genes hypermethylated in colorectal cancer
- (2011) Paulina Kober et al. MOLECULAR CARCINOGENESIS
- gp130 at the nexus of inflammation, autoimmunity, and cancer
- (2010) J. S. Silver et al. JOURNAL OF LEUKOCYTE BIOLOGY
- High-Resolution, Small Animal Radiation Research Platform With X-Ray Tomographic Guidance Capabilities
- (2008) John Wong et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Ciliary Neurotrophic Factor, Cardiotrophin-like Cytokine, and Neuropoietin Share a Conserved Binding Site on the Ciliary Neurotrophic Factor Receptor α Chain
- (2008) François Rousseau et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now